Doxara Capital LP is an investment advisor that provides discretionary investment management to institutional clients. Doxara employs a market-neutral healthcare and therapeutics-focused strategy, investing long and short in publicly traded pharmaceuticals and bio-tech companies in the U.S., EU, and Japan. The firm integrates long-term, bottom-up, fundamental analysis that incorporates an understanding of market inefficiencies and perceptions.
Detailed fee information is not available for this advisor. View their full brochure on SEC.gov for fee details.